CN Patent

CN111788182B — 毒蕈碱性乙酰胆碱受体m4的拮抗剂

Assigned to Vanderbilt University · Expires 2023-09-26 · 3y expired

What this patent protects

本文披露了3‑氮杂二环[3.1.0]己烷‑6‑胺化合物，其可用作毒蕈碱性乙酰胆碱受体M 4 (mAChR M 4 )的拮抗剂。本文还披露了制造这些化合物的方法、包含这些化合物的药物组合物、以及使用这些化合物和组合物治疗障碍的方法。

USPTO Abstract

本文披露了3‑氮杂二环[3.1.0]己烷‑6‑胺化合物，其可用作毒蕈碱性乙酰胆碱受体M 4 (mAChR M 4 )的拮抗剂。本文还披露了制造这些化合物的方法、包含这些化合物的药物组合物、以及使用这些化合物和组合物治疗障碍的方法。

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: CN111788182B
Jurisdiction: CN
Classification: —
Expires: 2023-09-26
Drug substance claim: No
Drug product claim: No
Assignee: Vanderbilt University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.